enVVeno Medical to Showcase the enVVe System at 38th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium
enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company"), today announced that it will present its investigational enVVe System® at the 38th annual Transcatheter Cardiovascular Conference (TCT®) in San Diego, CA. The presentation, titled "Changing the Treatment Paradigm for Deep Venous Disease: Transcatheter Replacement Venous Valve," will be delivered by Rob Berman, Chief Executive Officer of enVVeno Medical, during the...
Read more








